122 related articles for article (PubMed ID: 15575964)
1. Expression of the Tpl2/Cot oncogene in human T-cell neoplasias.
Christoforidou AV; Papadaki HA; Margioris AN; Eliopoulos GD; Tsatsanis C
Mol Cancer; 2004 Dec; 3(1):34. PubMed ID: 15575964
[TBL] [Abstract][Full Text] [Related]
2. A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiation.
Sugimoto K; Ohata M; Miyoshi J; Ishizaki H; Tsuboi N; Masuda A; Yoshikai Y; Takamoto M; Sugane K; Matsuo S; Shimada Y; Matsuguchi T
J Clin Invest; 2004 Sep; 114(6):857-66. PubMed ID: 15372110
[TBL] [Abstract][Full Text] [Related]
3. Functional roles of Cot/Tpl2 in mast cell responses to lipopolysaccharide and FcεRI-clustering.
Chiba N; Kakimoto K; Masuda A; Matsuguchi T
Biochem Biophys Res Commun; 2010 Nov; 402(1):1-6. PubMed ID: 20732300
[TBL] [Abstract][Full Text] [Related]
4. Serine/threonine kinase, Cot/Tpl2, regulates renal cell apoptosis in ischaemia/reperfusion injury.
Yaomura T; Tsuboi N; Urahama Y; Hobo A; Sugimoto K; Miyoshi J; Matsuguchi T; Reiji K; Matsuo S; Yuzawa Y
Nephrology (Carlton); 2008 Oct; 13(5):397-404. PubMed ID: 18518937
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of tumor progression loci-2 (Tpl2) kinase and tumor necrosis factor alpha (TNF-alpha) production: selectivity and in vivo antiinflammatory activity of novel 8-substituted-4-anilino-6-aminoquinoline-3-carbonitriles.
Green N; Hu Y; Janz K; Li HQ; Kaila N; Guler S; Thomason J; Joseph-McCarthy D; Tam SY; Hotchandani R; Wu J; Huang A; Wang Q; Leung L; Pelker J; Marusic S; Hsu S; Telliez JB; Hall JP; Cuozzo JW; Lin LL
J Med Chem; 2007 Sep; 50(19):4728-45. PubMed ID: 17715908
[TBL] [Abstract][Full Text] [Related]
6. Cot/tpl2 activity is required for TLR-induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expression.
López-Peláez M; Soria-Castro I; Boscá L; Fernández M; Alemany S
Eur J Immunol; 2011 Jun; 41(6):1733-41. PubMed ID: 21469113
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the Tpl-2/Cot oncogene in human breast cancer.
Sourvinos G; Tsatsanis C; Spandidos DA
Oncogene; 1999 Sep; 18(35):4968-73. PubMed ID: 10490831
[TBL] [Abstract][Full Text] [Related]
9. Deregulated activation of oncoprotein kinase Tpl2/Cot in HTLV-I-transformed T cells.
Babu G; Waterfield M; Chang M; Wu X; Sun SC
J Biol Chem; 2006 May; 281(20):14041-7. PubMed ID: 16565081
[TBL] [Abstract][Full Text] [Related]
10. Cot/Tpl2 and PKCzeta cooperate in the regulation of the transcriptional activity of NFATc2 through the phosphorylation of its amino-terminal domain.
Gómez-Casero E; San-Antonio B; Iñiguez MA; Fresno M
Cell Signal; 2007 Aug; 19(8):1652-61. PubMed ID: 17398070
[TBL] [Abstract][Full Text] [Related]
11. In vitro selection of adenine-dependent ribozyme against Tpl2/Cot oncogene.
Li YL; Vergne J; Torchet C; Maurel MC
FEBS J; 2009 Jan; 276(1):303-14. PubMed ID: 19054068
[TBL] [Abstract][Full Text] [Related]
12. Sterile inflammation in acetaminophen-induced liver injury is mediated by Cot/tpl2.
Sanz-Garcia C; Ferrer-Mayorga G; González-Rodríguez Á; Valverde AM; Martín-Duce A; Velasco-Martín JP; Regadera J; Fernández M; Alemany S
J Biol Chem; 2013 May; 288(21):15342-51. PubMed ID: 23572518
[TBL] [Abstract][Full Text] [Related]
13. Cot/Tpl2 regulates IL-23 p19 expression in LPS-stimulated macrophages through ERK activation.
Kakimoto K; Musikacharoen T; Chiba N; Bandow K; Ohnishi T; Matsuguchi T
J Physiol Biochem; 2010 Mar; 66(1):47-53. PubMed ID: 20405269
[TBL] [Abstract][Full Text] [Related]
14. Cot/tpl2 participates in the activation of macrophages by adiponectin.
Sanz-Garcia C; Nagy LE; Lasunción MA; Fernandez M; Alemany S
J Leukoc Biol; 2014 Jun; 95(6):917-30. PubMed ID: 24532642
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of functional single nucleotide polymorphisms of different genes coding for the immunoregulatory molecules in patients with monoclonal large granular lymphocyte lymphocytosis.
Garrido P; Almeida J; Romero JM; Cantón J; Sandberg Y; Bárcena P; Lima M; Langerak AW; Orfao A; Ruiz-Cabello F
Hum Immunol; 2008 Feb; 69(2):101-7. PubMed ID: 18361934
[TBL] [Abstract][Full Text] [Related]
16. Cot/tpl2 (MAP3K8) mediates myeloperoxidase activity and hypernociception following peripheral inflammation.
Soria-Castro I; Krzyzanowska A; Pelaéz ML; Regadera J; Ferrer G; Montoliu L; Rodríguez-Ramos R; Fernández M; Alemany S
J Biol Chem; 2010 Oct; 285(44):33805-15. PubMed ID: 20736176
[TBL] [Abstract][Full Text] [Related]
17. Cot kinase regulation of IL-2 production in Jurkat T cells.
Ballester A; Tobeña R; Lisbona C; Calvo V; Alemany S
J Immunol; 1997 Aug; 159(4):1613-8. PubMed ID: 9257820
[TBL] [Abstract][Full Text] [Related]
18. Identification of a selective thieno[2,3-c]pyridine inhibitor of COT kinase and TNF-alpha production.
Cusack K; Allen H; Bischoff A; Clabbers A; Dixon R; Fix-Stenzel S; Friedman M; Gaumont Y; George D; Gordon T; Grongsaard P; Janssen B; Jia Y; Moskey M; Quinn C; Salmeron A; Thomas C; Wallace G; Wishart N; Yu Z
Bioorg Med Chem Lett; 2009 Mar; 19(6):1722-5. PubMed ID: 19217782
[TBL] [Abstract][Full Text] [Related]
19. Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren's syndrome-an important but under-recognized association.
Friedman J; Schattner A; Shvidel L; Berrebi A
Semin Arthritis Rheum; 2006 Apr; 35(5):306-11. PubMed ID: 16616153
[TBL] [Abstract][Full Text] [Related]
20. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
Tendler CL; Greenberg SJ; Burton JD; Danielpour D; Kim SJ; Blattner WA; Manns A; Waldmann TA
J Cell Biochem; 1991 Aug; 46(4):302-11. PubMed ID: 1757474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
